Huapont Life Sciences controlling shareholder pledges additional shares

Huapont Life Sciences announced its controlling shareholder, Chongqing Huapont Zhuoyuan Technology Co., Ltd. (Huapont Zhuoyuan), and de facto controller, Zhang Songshan, have pledged a portion of their company shares. Huapont Zhuoyuan pledged 19,000,000 shares, representing 5.13% of its total holdings and 0.96% of the company's total share capital, with a pledge start date of August 25, 2025. Zhang Songshan also made two pledges: 5,000,000 shares (4.27% of his holdings, 0.25% of total share capital) and 24,910,000 shares (21.27% of his holdings, 1.26% of total share capital), both with the same pledge start date.

As of the announcement date, the cumulative pledged shares by Huapont Zhuoyuan, Zhang Songshan, Zhang Yizhuo, and Zhao Danlin total 317,900,000 shares, representing 58.54% of their collective holdings and 16.06% of the company's total share capital. The financing from these pledges is not for the company’s operational needs.

Within the next year, 292,500,000 pledged shares are set to mature, accounting for 53.87% of their combined holdings and 14.77% of the company's total share capital, with a corresponding financing balance of 56,445万元. The company stated that the pledging parties have the ability to repay the loans through their own or self-raised funds.